ABT vs. NVO: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and NVO, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With ABT at 231.49 billion USD and NVO at 305.18 billion USD, their market capitalizations sit in the same ballpark.
ABT’s beta of 0.74 points to much larger expected swings compared to NVO’s calmer 0.21, suggesting both higher upside and downside potential.
NVO is an ADR, letting U.S. buyers tap its non-U.S. business directly, unlike ABT, which is purely domestic.
| Symbol | ABT | NVO |
|---|---|---|
| Company Name | Abbott Laboratories | Novo Nordisk A/S |
| Country | US | DK |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Drug Manufacturers - General |
| CEO | Mr. Robert B. Ford | Mr. Lars Fruergaard Jorgensen |
| Price | 133.05 USD | 68.2 USD |
| Market Cap | 231.49 billion USD | 305.18 billion USD |
| Beta | 0.74 | 0.21 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | April 30, 1981 |
| ADR | No | Yes |
Performance Comparison
This chart compares the performance of ABT and NVO over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABT and NVO, please refer to the table below.
| Symbol | ABT | NVO |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.22 | 18.77 |
| Forward PEG Ratio (TTM) | 1.73 | 1.31 |
| Price-to-Sales Ratio (P/S, TTM) | 5.47 | 6.53 |
| Price-to-Book Ratio (P/B, TTM) | 2.48 | 14.17 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 34.77 | 26.48 |
| EV-to-EBITDA (TTM) | 22.97 | 12.80 |
| EV-to-Sales (TTM) | 5.63 | 6.79 |
| EV-to-Free Cash Flow (TTM) | 35.78 | 27.55 |
Dividend Comparison
NVO stands out with a 2.58% dividend yield—around 50% above ABT’s 1.71%—highlighting its emphasis on generous payouts.
| Symbol | ABT | NVO |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 2.58% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABT and NVO, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- NVO’s current ratio of 0.74 indicates its assets may not cover near-term debts, whereas ABT at 1.78 maintains healthy liquidity.
- NVO posts a quick ratio of 0.56, indicating limited coverage of short-term debts from its most liquid assets—while ABT at 1.27 enjoys stronger liquidity resilience.
| Symbol | ABT | NVO |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 0.74 |
| Quick Ratio (TTM) | 1.27 | 0.56 |
| Debt-to-Equity Ratio (TTM) | 0.14 | 0.86 |
| Debt-to-Assets Ratio (TTM) | 0.16 | 0.24 |
| Interest Coverage Ratio (TTM) | 15.39 | 17.84 |